All the news Showing 10 of 52 articles from: Hepatocellular carcinoma (HCC)Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Secondary liver cancer after colorectal cancer more common in people with chronic hepatitis B Keith Alcorn / 22 January 2018 The spread of cancer from the bowel to the liver – metastasis – is more likely to occur in people with chronic hepatitis B infection, a Chinese study published in ... Liver cancer incidence after HCV therapy linked to risk factors, not treatment Healio Hepatology / 11 December 2017 Elevated HBV surface antigen, viral load increases liver cancer risk Healio Hepatology / 06 December 2017 Nivolumab improves outcomes in liver cancer study Liz Highleyman / 13 November 2017 Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease stabilisation in people with hepatocellular carcinoma (HCC) in the CheckMate ... Curing hepatitis C with DAAs linked to 71% reduction in liver cancer Liz Highleyman / 30 October 2017 People who achieved a sustained response to hepatitis C treatment lowered their risk of hepatocellular carcinoma by around 70%, regardless of whether they were treated with new direct-acting antivirals (DAAs) or older interferon-based therapy, ... HCV clearance lowers liver cancer risk by 70% no matter drug of choice Healio / 25 October 2017 Deaths Rates of Liver Cirrhosis Exceed Those of 5 Major Cancers AASLD / 23 October 2017 Age, comorbidities greater impact on HCC rates than DAA therapy Healio Hepatology / 23 October 2017 Nivolumab increases survival for people with advanced liver cancer Liz Highleyman / 22 April 2017 The checkpoint inhibitor nivolumab (Opdivo) produced durable responses, prolonged overall survival, and was generally well tolerated as a treatment for advanced liver cancer that did not respond to standard treatment, researchers reported on ... Nivolumab produces durable responses & long-term survival in severe liver cancer patients Eurekalert Inf Dis / 21 April 2017 ← Prev12345...6Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds